InMed Pharmaceuticals Inc (INM : NASDAQ)
Common Stock
$1.75
USD
+0.07 (4.17%)
Last updated: 2026-11-04
Follow INM
INM
InMed Pharmaceuticals Inc
WealthAwesomePerformance
1 Day
+941.67%
1 Week
+994.30%
1 Month
+1215.79%
YTD
+1074.50%
Key Statistics
Market Cap
$9.23M
52W High
$23.30
52W Low
$5.75
P/E Ratio
-
50 Day MA
$1.38
200 Day MA
$1.20
Beta
0.99
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/4/2026 | $1.81 | $1.83 | $1.62 | $1.75 | $17.50 | 11,670 |
| 11/3/2026 | $1.53 | $1.77 | $1.51 | $1.68 | $1.68 | 173,728 |
| 11/2/2026 | $1.60 | $1.65 | $1.49 | $1.63 | $1.63 | 136,351 |
| 10/30/2026 | $1.55 | $1.61 | $1.51 | $1.60 | $1.60 | 36,700 |
| 10/29/2026 | $1.59 | $1.64 | $1.59 | $1.63 | $1.63 | 37,271 |
| 10/28/2026 | $1.63 | $1.67 | $1.59 | $1.60 | $1.60 | 40,653 |
| 10/27/2026 | $1.59 | $1.68 | $1.54 | $1.59 | $1.59 | 114,764 |
| 10/26/2026 | $1.44 | $1.62 | $1.41 | $1.59 | $1.59 | 293,334 |
| 10/23/2026 | $1.32 | $1.54 | $1.32 | $1.44 | $1.44 | 125,900 |
| 10/22/2026 | $1.36 | $1.38 | $1.33 | $1.33 | $1.33 | 8,292 |
Analyst Price Targets
Based on analyst covering INM · as of Sep 17, 2026
Wall Street analysts forecast INM stock price to rise 1042.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
US$20.00
+1042.9% Upside
Current Price
US$1.75
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on INM's historical volatility
30-Day Vol
678.6%
Annualized
90-Day Vol
398.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$20.92
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$18.57 | US$1.79 – US$193.08 |
| 60 trading days | US$19.71 | US$0.72 – US$540.47 |
| 90 trading days | US$20.92 | US$0.36 – US$1207.30 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
Financials
- Revenue (TTM)
- $4.94M
- EBITDA
- $-9.69M
- Profit Margin
- 0.00%
- ROE (TTM)
- -156.77%
- EPS (Diluted)
- -2.76
- Book Value
- 0.20
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About INM.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| OMH | Ohmyhome Limited Ordinary Shares | $15.55 | +432.53% |
| CRIS | Curis Inc | $1.11 | +56.34% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.04 | +54.07% |
| RFAIR | RF Acquisition Corp II Right | $0.24 | +50.00% |
| CRCT | Cricut Inc | $8.88 | +48.74% |
| LYEL | Lyell Immunopharma Inc | $15.43 | +43.27% |
| GENVR | Gen Digital Inc. Contingent Value Rights | $4.03 | +42.40% |
| DKI | DarkIris Inc. | $2.08 | +38.67% |